The profile of inflammatory and metabolic response in children undergoing heart transplantation

Xiaoyang Yu1, Bodil Larsen, Simon Urschel

  • 1Division of Pediatric Cardiology, Stollery Children's Hospital, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.

Clinical Transplantation
|December 16, 2011
PubMed

Insights

Pediatric heart transplantation (HTx) shows significant inflammatory and metabolic changes. C-reactive protein (CRP) and prealbumin (PA) levels indicate a heightened response post-surgery, influenced by cardiopulmonary bypass duration.

Area of Science:

  • Pediatric Cardiology
  • Transplant Immunology
  • Biomarkers in Critical Care

Background:

  • Clinical outcomes after pediatric heart transplantation (HTx) are influenced by inflammatory and metabolic responses, but these are not well-characterized in this population.
  • Understanding these perioperative changes is crucial for optimizing patient management and improving long-term results.

Purpose of the Study:

  • To investigate the perioperative changes in inflammatory (C-reactive protein, CRP) and metabolic (prealbumin, PA) markers in children undergoing heart transplantation.
  • To identify factors influencing these biomarker changes during the perioperative period.

Main Methods:

  • Prospective study of 38 children undergoing HTx.
  • Collection of data on CRP, PA, white blood cell counts, medication dosages, cultures, and surgical parameters (CPB, ischemia time, cross-clamp time) before and up to one month after HTx.
  • Statistical analysis to correlate biomarker levels with clinical and surgical variables.

Main Results:

  • CRP levels were elevated before HTx, peaked on postoperative days 1-2, and decreased by one month. PA levels decreased initially post-HTx before gradually increasing.
  • Postoperative CRP levels correlated positively with epinephrine dosage and cardiopulmonary bypass (CPB) duration.
  • Prealbumin levels showed a positive correlation with patient age.

Conclusions:

  • Children undergoing heart transplantation exhibit a distinct inflammatory and metabolic response profile perioperatively.
  • The intensity of this response is significantly influenced by the duration of cardiopulmonary bypass and the patient's cardiovascular function.
  • These findings highlight the importance of monitoring CRP and PA in pediatric HTx patients to assess recovery and potential complications.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...